Clinical Practice Guideline on Primary Central Nervous System Lymphoma

Title: Clinical Practice Guideline on Primary Central Nervous System Lymphoma
Edition: Original
Classification: Standard guideline
Field: Comprehensive guideline
Countries and regions: China
Guidelines users: Clinical professionals (including clinical practitioners, pharmacists and nurses)
Evidence classification method:
Development unit: The Chinese Neurosurgical Society of the Chinese Medical Association, The Society of Hematological malignancies of China Anti-Cancer Association
Registration time: 2021-01-01
Registration number: IPGRP-2021CN001
Purpose of the guideline: This guideline followed the standard method and process of developing an evidence-based clinical practice guideline, aims to standardize the diagnosis and treatment of primary central nervous system lymphoma, and provides the appropriate support for health workers and practitioners in the field of primary central nervous system lymphoma.